The 9 analysts offering 1 year price forecasts for PSM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to PSM in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PSM EPS for the last quarter is 0.04 CHF despite the estimation of 0.15 CHF. In the next quarter EPS is expected to reach 0.74 CHF. Track more of PROSIEBENSAT1 MED. financials and stay on top of what is up with the company.
In the next quarter PROSIEBENSAT1 MED. revenue is expected to reach 1.22 B CHF. Check out PROSIEBENSAT1 MED. revenue and earnings and make informed decisions.
According to analysts, PSM price target is 7.44 CHF with a max estimate of 12.08 CHF and a min estimate of 4.92 CHF. Check if this forecast comes true in a year, meanwhile watch PROSIEBENSAT1 MED. stock price chart and keep track of the current situation with PSM news and stock market news.
We've gathered opinions of 10 analysts rating PSM stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.